SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Robertson Nicola) srt2:(2020-2021)"

Search: WFRF:(Robertson Nicola) > (2020-2021)

  • Result 1-2 of 2
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Lingam, Ingran, et al. (author)
  • Serial blood cytokine and chemokine mRNA and microRNA over 48h are insult specific in a piglet model of inflammation-sensitized hypoxia-ischaemia.
  • 2021
  • In: Pediatric research. - : Springer Science and Business Media LLC. - 1530-0447 .- 0031-3998. ; 89:3, s. 464-475
  • Journal article (peer-reviewed)abstract
    • Exposure to inflammation exacerbates injury in neonatal encephalopathy (NE). We hypothesized that brain biomarker mRNA, cytokine mRNA and microRNA differentiate inflammation (E. coli LPS), hypoxia (Hypoxia), and inflammation-sensitized hypoxia (LPS+Hypoxia) in an NE piglet model.Sixteen piglets were randomized: (i) LPS 2μg/kg bolus; 1μg/kg infusion (LPS; n=5), (ii) Saline with hypoxia (Hypoxia; n=6), (iii) LPS commencing 4h pre-hypoxia (LPS+Hypoxia; n=5). Total RNA was acquired at baseline, 4h after LPS and 1, 3, 6, 12, 24, 48h post-insult (animals euthanized at 48h). Quantitative PCR was performed for cytokines (IL1A, IL6, CXCL8, IL10, TNFA) and brain biomarkers (ENO2, UCHL1, S100B, GFAP, CRP, BDNF, MAPT). MicroRNA was detected using GeneChip (Affymetrix) microarrays. Fold changes from baseline were compared between groups and correlated with cell death (TUNEL) at 48h.Within 6h post-insult, we observed increased IL1A, CXCL8, CCL2 and ENO2 mRNA in LPS+Hypoxia and LPS compared to Hypoxia. IL10 mRNA differentiated all groups. Four microRNAs differentiated LPS+Hypoxia and Hypoxia: hsa-miR-23a, 27a, 31-5p, 193-5p. Cell death correlated with TNFA (R=0.69; p<0.01) at 1-3h and ENO2 (R=-0.69; p=0.01) at 48h.mRNA and miRNA differentiated hypoxia from inflammation-sensitized hypoxia within 6h in a piglet model. This information may inform human studies to enable triage for tailored neuroprotection in NE.Early stratification of infants with neonatal encephalopathy is key to provide tailored neuroprotection.IL1A, CXCL8, IL10, CCL2 and NSE mRNA are promising biomarkers of inflammation-sensitized hypoxia.IL10 mRNA levels differentiated all three pathological states; fold changes from baseline was the highest in LPS+Hypoxia animals, followed by LPS and Hypoxia at 6h.miR-23, -27, -31-5p and -193-5p were significantly upregulated within 6h of a hypoxia insult.Functional analysis highlighted the diverse roles of miRNA in the cellular processes.
  •  
2.
  • Olson, Linus, et al. (author)
  • Phase-Changing Glauber Salt Solution for Medical Applications in the 28-32 degrees C Interval
  • 2021
  • In: Materials. - : MDPI AG. - 1996-1944. ; 14:23
  • Journal article (peer-reviewed)abstract
    • (1) Background: The field of medicine requires simple cooling materials. However, there is little knowledge documented about phase change materials (PCM) covering the range of 28 to 40 degrees Celsius, as needed for medical use. Induced mild hypothermia, started within 6 h after birth, is an emerging therapy for reducing death and severe disabilities in asphyxiated infants. Currently, this hypothermia is accomplished with equipment that needs a power source and a liquid supply. Neonatal cooling is more frequent in low-resource settings, where ~1 million deaths are caused by birth-asphyxia. (2) Methods: A simple and safe cooling method suitable for medical application is needed for the 28 to 37.5 degrees C window. (3) Results: Using empirical experiments in which the ingredients in Glauber salt were changed, we studied the effects of temperature on material in the indicated temperature range. The examination, in a controlled manner, of different mixtures of NaCl, Na2SO4 and water resulted in a better understanding of how the different mixtures act and how to compose salt solutions that can satisfy clinical cooling specifications. (4) Conclusions: Our Glauber salt solution is a clinically suited PCM in the temperature interval needed for the cooling of infants suffering from asphyxia.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-2 of 2

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view